RT Journal Article
SR Electronic
T1 A Noncooperative Game Analysis for Controlling COVID-19 Outbreak
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.22.20110783
DO 10.1101/2020.05.22.20110783
A1 Bairagi, Anupam Kumar
A1 Masud, Mehedi
A1 Kim, Do Hyeon
A1 Munir, Md. Shirajum
A1 Al Nahid, Abdullah
A1 Abedin, Sarder Fakhrul
A1 Alam, Kazi Masudul
A1 Biswas, Sujit
A1 Alshamrani, Sultan S
A1 Han, Zhu
A1 Hong, Choong Seon
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.22.20110783.abstract
AB COVID-19 is a global epidemic. Till now, there is no remedy for this epidemic. However, isolation and social distancing are seemed to be effective to control this pandemic. In this paper, we provide an analytical model on the effectiveness of the sustainable lockdown policy that accommodates both isolation and social distancing features of the individuals. To promote social distancing, we analyze a noncooperative game environment that provides an incentive for maintaining social distancing. Furthermore, the sustainability of the lockdown policy is also interpreted with the help of a game-theoretic incentive model for maintaining social distancing. Finally, an extensive numerical analysis is provided to study the impact of maintaining a social-distancing measure to prevent the Covid-19 outbreak. Numerical results show that the individual incentive increases more than 85% with an increasing percentage of home isolation from 25% to 100% for all considered scenarios. The numerical results also demonstrate that in a particular percentage of home isolation, the individual incentive decreases with an increasing number of individuals.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo need to apply due to analytical manuscript in health economicsFunding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:In this manuscript, the authors do not need to examine IRB/oversight bodyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWold Health Organization, “Rolling updates on event of novel coronavirus 2019 disease (covid-19),” Available Online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/ events-as-they-happen, (Accessed on 20 April, 2020). Worldmeter, “COVID-19 Coronavirus Pandemic,” Available Online: https://www.worldometers.info/coronavirus/ Johns Hopkins University Medicine, “Coronavirus resource center,” Available Online: https://coronavirus.jhu.edu/ (Accessed on April 20, 2020). European Centre for Disease Prevention and Control, “Situation update worldwide,” Available Online: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases, (Accessed on April 20, 2020). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases